Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Treatment of the Immune-Related Adverse Effects of Immune Checkpoint Inhibitors

Treatment of the Immune-Related Adverse Effects of Immune Checkpoint Inhibitors This review discusses the most common immune-related adverse effects of immune checkpoint inhibitor therapy with ipilimumab, nivolumab, and pembrolizumab and provides suggestions for optimal treatment. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Oncology American Medical Association

Treatment of the Immune-Related Adverse Effects of Immune Checkpoint Inhibitors

Loading next page...
 
/lp/american-medical-association/treatment-of-the-immune-related-adverse-effects-of-immune-checkpoint-8zCZgB4Alk

References (77)

Publisher
American Medical Association
Copyright
Copyright 2016 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2374-2437
eISSN
2374-2445
DOI
10.1001/jamaoncol.2016.1051
pmid
27367787
Publisher site
See Article on Publisher Site

Abstract

This review discusses the most common immune-related adverse effects of immune checkpoint inhibitor therapy with ipilimumab, nivolumab, and pembrolizumab and provides suggestions for optimal treatment.

Journal

JAMA OncologyAmerican Medical Association

Published: Oct 30, 2016

There are no references for this article.